The use of blood coagulation laboratory parameters for assessment of bleeding risk during radiofrequency ablation procedure in atrial fibrillation patients receiving dabigatran etexilate
Автор: Usenkov S. Yu., Batalov R.E., Borisova E.V., Khlynin M.S., Archakov E.A., Popov S.V.
Журнал: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk
Рубрика: Клинические исследования
Статья в выпуске: 4 т.32, 2017 года.
Бесплатный доступ
The article presents the results of the analysis of hemostasis parameters in atrial fibrillation patients with and without anticoagulation therapy with dabigatran etexilate in the perioperative period of the arrhythmia ablation. We evaluated the capabilities of using the conventional indicators of the blood coagulation in atrial fibrillation patients receiving dabigatran etexilate to assess the possible risk of bleeding in the perioperative period of radiofrequency ablation.
Dabigatran etexilate, atrial fibrillation, anticoagulation therapy
Короткий адрес: https://sciup.org/149125180
IDR: 149125180 | DOI: 10.29001/2073-8552-2017-32-4-17-22
